2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

$173.3M

Market Cap • 11/18/2024

2021

(3 years)
Founded

2021

(3 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Cambridge

Headquarters • Massachusetts